A detailed history of Russell Investments Group, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 2,068,337 shares of JNJ stock, worth $324 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
2,068,337
Previous 2,082,731 0.69%
Holding current value
$324 Million
Previous $329 Million 8.24%
% of portfolio
0.5%
Previous 0.53%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $2.08 Million - $2.27 Million
-14,394 Reduced 0.69%
2,068,337 $302 Million
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $42.7 Million - $44.8 Million
275,127 Added 15.22%
2,082,731 $329 Million
Q4 2023

Feb 05, 2024

SELL
$145.6 - $158.88 $14.4 Million - $15.7 Million
-98,713 Reduced 5.18%
1,807,604 $283 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $67.2 Million - $75.3 Million
-431,437 Reduced 18.46%
1,906,317 $297 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $11.7 Million - $12.5 Million
-75,498 Reduced 3.13%
2,337,754 $387 Million
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $29.8 Million - $35.6 Million
197,513 Added 8.91%
2,413,252 $374 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $8.73 Million - $9.8 Million
-54,491 Reduced 2.4%
2,215,739 $391 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $60.1 Million - $66.8 Million
-372,303 Reduced 14.09%
2,270,230 $371 Million
Q2 2022

Jul 29, 2022

SELL
$168.19 - $186.01 $47.9 Million - $53 Million
-284,685 Reduced 9.73%
2,642,533 $469 Million
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $9.03 Million - $10.2 Million
-57,070 Reduced 1.91%
2,927,218 $520 Million
Q4 2021

Jan 21, 2022

SELL
$155.93 - $173.01 $21.7 Million - $24 Million
-138,851 Reduced 4.45%
2,984,288 $511 Million
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $70.6 Million - $78.4 Million
436,881 Added 16.26%
3,123,139 $506 Million
Q2 2021

Aug 04, 2021

SELL
$159.48 - $171.07 $50.3 Million - $53.9 Million
-315,249 Reduced 10.5%
2,686,258 $442 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $32.1 Million - $35.7 Million
209,702 Added 7.51%
3,001,507 $494 Million
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $35.5 Million - $40.7 Million
258,866 Added 10.22%
2,791,805 $438 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $39.2 Million - $43 Million
-279,502 Reduced 9.94%
2,532,939 $375 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $80.2 Million - $96.8 Million
-622,652 Reduced 18.13%
2,812,441 $394 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $50 Million - $69.2 Million
-449,696 Reduced 11.58%
3,435,093 $453 Million
Q4 2019

Jan 29, 2020

BUY
$127.5 - $146.44 $30.6 Million - $35.1 Million
239,922 Added 6.58%
3,884,789 $566 Million
Q3 2019

Nov 01, 2019

SELL
$126.95 - $142.14 $24.9 Million - $27.8 Million
-195,768 Reduced 5.1%
3,644,867 $471 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $68.9 Million - $75.8 Million
-525,213 Reduced 12.03%
3,840,635 $537 Million
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $17.9 Million - $19.9 Million
142,288 Added 3.37%
4,365,848 $609 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $9.9 Million - $11.9 Million
80,632 Added 1.95%
4,223,560 $542 Million
Q3 2018

Oct 26, 2018

SELL
$121.58 - $142.88 $72.2 Million - $84.9 Million
-594,231 Reduced 12.54%
4,142,928 $573 Million
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $136 Million - $150 Million
-1,137,909 Reduced 19.37%
4,737,159 $576 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $26.1 Million - $30.9 Million
208,336 Added 3.68%
5,875,068 $750 Million
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $21.4 Million - $23.4 Million
163,004 Added 2.96%
5,666,732 $796 Million
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $713 Million - $745 Million
5,503,728
5,503,728 $715 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.